Platelets play a key role in the regulation of haemostasis,
clot stability and retraction, vascular repair, and exert an
increasingly recognised function in host defence. Conversely,
platelets are also implied in many pathophysiological
processes, such as thrombosis, haemorrhage, inflammation,
atherogenesis, tumour growth and metastasis.
Thus quantitative and qualitative platelet alterations
have been associated with distinct clinical diseases, including
cardiovascular diseases, diabetes, tumour
metastasis and sepsis, and consequently different diagnostic
platelet markers are correlated with the prognosis
and severity of these diseases. While primary platelet
functional abnormalities are very rare diseases, acquired
platelet function disorders are rather frequent and occur
in the context of many diseases and in association with
several drugs. Furthermore, the introduction of a great
variety of different anti-platelet agents leads to iatrogenic
states of therapeutically reduced platelet function. This
review provides an overview of the methodological principles
of platelet function analysis, the currently available
diagnostic devices, the application and suitability for the
diagnosis of different platelet function disorders and the
restrictions of each method, to promote an optimal selection
of diagnostic tests.